Company: HCWB
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-283238
Chunk: 8

Company: HCW Biologics Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 6
Chunk 8
---
The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index, which Exhibit Index is incorporated herein by reference. 

     ExhibitNumber 
      
     Incorporated by Reference  
     FiledHerewith  

     Description 
     Form  
     File No.  
     Exhibit No.
     Filing Date  

     10.1
     Equity Purchase Agreement, dated February 20, 2025, between the Company and Square Gate Master Fund - Series 4.
     8-K
     011-40591
     10.1
     02/21/2025

     10.2
     Registration Rights Agreement, dated February 20, 2025, between the Company and Square Gate Master Fund - Series 4
     8-K
     011-40591
     10.2
     02/21/2025

     10.3 
     Definitive Proxy Statement dated February 21, 2025, on Form 14A, including Appendices
     10-K
     011-40591
     10.35
     03/28/2025

     10.4 
     Form of Promissory Note, dated May 8, 2025, between the Company and Holder
     10-Q
     011-40591
     10.4
     05/15/2025

     10.5
     Form of Guaranty and Pledge Agreement, dated May 8, 2025, between the Dr. Hing C. Wong and Lender
     10-Q
     011-40591
     10.5
     05/15/2025

     10.6 
     Form of Unsecured Convertible Promissory Note, dated May 5, 2025, between the Company and Holder
     10-Q
     011-40591
     10.6
     05/15/2025

     10.7
     Form of Placement Agency Agreement, dated May 13, 2025, between Company and Maxim Group LLC
     8-K
     011-40591
     10.1
     05/15/2025

     10.8
     Form of Securities Purchase Agreement, dated May 13, 2025, between the Company and Purch